Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetic Hemochromatosis”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Not applicableLooking for participantsNCT03131427
What this trial is testing

China Registry for Genetic / Metabolic Liver Diseases

Who this might be right for
Genetic/Metabolic Liver Diseases
Beijing Friendship Hospital 20,000
Testing effectiveness (Phase 2)Study completedNCT01044186
What this trial is testing

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 30
Not applicableStudy completedNCT00005559
What this trial is testing

Statistical Basis for Hemochromatosis Screening

Who this might be right for
Blood DiseaseHemochromatosis
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT06137079
What this trial is testing

"Iron Overload and Endocrinological Diseases"

Who this might be right for
Iron OverloadThalassemia MajorThalassemia Intermedia+2 more
Azienda Ospedaliero-Universitaria di Modena 62
Testing effectiveness (Phase 2)Study completedNCT00395629
What this trial is testing

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

Who this might be right for
Iron OverloadHereditary Hemochromatosis
Novartis Pharmaceuticals 49
Early research (Phase 1)Ended earlyNCT05238207
What this trial is testing

Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers

Who this might be right for
Hereditary Hemochromatosis
Bond Biosciences 24
Not applicableStudy completedNCT00068159
What this trial is testing

Cardiac Function in Patients With Hereditary Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis
National Heart, Lung, and Blood Institute (NHLBI) 70
Not applicableLooking for participantsNCT05335603
What this trial is testing

An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis

Who this might be right for
Chronic Liver Disease
University of Copenhagen 335
Not applicableStudy completedNCT00213772
What this trial is testing

Risk Factors of Porphyria Cutanea Tarda (PCT)

Who this might be right for
Porphyria Cutanea Tarda
University Hospital, Strasbourg, France 280
Not applicableStudy completedNCT01572922
What this trial is testing

Massive Iron Deposit Assessment

Who this might be right for
Iron OverloadExcessive Body Iron Burden
St. Jude Children's Research Hospital 142
Testing effectiveness (Phase 2)Study completedNCT00600938
What this trial is testing

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

Who this might be right for
Transfusional Iron OverloadTransfusional Hemosiderosis
Novartis Pharmaceuticals 197
Large-scale testing (Phase 3)Study completedNCT00171171
What this trial is testing

Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

Who this might be right for
Beta-ThalassemiaHemosiderosis
Novartis 252
Large-scale testing (Phase 3)UnknownNCT01511848
What this trial is testing

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

Who this might be right for
Beta-thalassemia MajorSickle Cell DiseaseIron Hemosiderosis
Ain Shams University 60
Not applicableStudy completedNCT02025543
What this trial is testing

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

Who this might be right for
Iron OverloadHemochromatosisHemosiderosis
University of Wisconsin, Madison 207
Post-approval studies (Phase 4)Study completedNCT00171301
What this trial is testing

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

Who this might be right for
Beta-thalassemia MajorHemosiderosisIron Overload+1 more
Novartis Pharmaceuticals 233
Early research (Phase 1)Study completedNCT00712738
What this trial is testing

Oral Nifedipine to Treat Iron Overload

Who this might be right for
ThalassemiaIron OverloadHemochromatosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 6
Testing effectiveness (Phase 2)Study completedNCT00067080
What this trial is testing

Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Anemia, Sickle Cell
Novartis Pharmaceuticals 195
Not applicableActive Not RecruitingNCT04779593
What this trial is testing

Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis

Who this might be right for
Haemochromatosis
Rennes University Hospital 239
Not applicableStudy completedNCT03743272
What this trial is testing

Repeatability and Reproducibility of Multiparametric MRI

Who this might be right for
Liver DiseasesPrimary Biliary CirrhosisNon-Alcoholic Fatty Liver Disease+6 more
Perspectum 61
Testing effectiveness (Phase 2)Study completedNCT01090323
What this trial is testing

Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).

Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals 185
Load More Results